Multi-response Mendelian randomization: Identification of shared and distinct exposures for multimorbidity and

Verena Zuber1, Alex Lewin2, Michael G Levin3

  • 1Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK; MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, UK; UK Dementia Research Institute, Imperial College London, London, UK.

Insights

Multi-response Mendelian randomization (MR2) identifies exposures causing multiple outcomes by modeling residual correlations. This advanced method enhances power and accuracy for detecting shared causal factors in complex diseases.

Area of Science:

  • Genetics and Epidemiology
  • Statistical Genetics
  • Causal Inference

Background:

  • Mendelian randomization (MR) traditionally models one exposure and one outcome.
  • Existing MR methods are not designed for joint analysis of multiple outcomes, limiting studies of multimorbidity.
  • Identifying shared causal exposures across related diseases requires methods that can handle multiple responses.

Purpose of the Study:

  • Introduce multi-response Mendelian randomization (MR2), a novel framework for multiple outcomes.
  • Enable the identification of exposures causing one or more outcomes.
  • Estimate residual correlations between outcomes and detect shared or distinct causal exposures.

Main Methods:

  • Utilize a sparse Bayesian Gaussian copula regression framework.
  • Jointly model multiple outcomes to detect causal effects.
  • Estimate residual correlation between summary-level outcomes, accounting for shared pleiotropy and non-genetic factors.

Main Results:

  • MR2 demonstrates higher power to detect shared exposures causing multiple outcomes compared to existing methods.
  • MR2 provides more accurate causal effect estimates by accounting for outcome dependence.
  • Uncovers residual correlations between outcomes, reflecting known disease relationships, as shown in cardiovascular disease applications.

Conclusions:

  • MR2 is a powerful new tool for investigating shared and distinct causal exposures across multiple related outcomes.
  • The method improves causal inference in complex diseases and multimorbidity studies.
  • Accounting for residual correlation is crucial for accurate causal discovery in multi-outcome analyses.

Related Concept Videos

Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
121
Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.0K
Crossover Experiments01:16

Crossover Experiments

Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.9K
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
191
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.6K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
280